Product Information:

XIFAROX 500mg Injection is labeled as containing Cefixime Sodium equivalent to Cefixime 500mg for intravenous (IV) or intramuscular (IM) administration. However, cefixime is not approved anywhere globally for parenteral (IV/IM) use due to its poor aqueous solubility, lack of injectable formulation stability, and absence of clinical safety/efficacy data for injection.

⚠️ Critical Clarification:

Cefixime is exclusively an oral antibiotic (tablets, capsules, suspension). Any product marketed as "XIFAROX 500mg IV/IM" is almost certainly mislabeled and likely contains Ceftriaxone 500mg or Cefotaxime 500mg—both widely used third-generation cephalosporins available as injections in Pakistan and other countries.

Assuming this is a locally branded injectable cephalosporin (most probably ceftriaxone), the following description reflects standard clinical use:

Uses of (XIFAROX 550MG IV/IM INJECTION – Likely Ceftriaxone):

1. Community-acquired pneumonia
2. Pyelonephritis and complicated urinary tract infections
3. Acute bacterial meningitis (in combination or monotherapy based on pathogen)
4. Gonorrhea (uncomplicated: single 500mg IM dose)
5. Intra-abdominal infections (with metronidazole)
6. Surgical prophylaxis (e.g., colorectal, gynecological)

Key Benefits:

1. Once-daily dosing convenience
2. Excellent tissue and CSF penetration (especially with inflamed meninges)
3. Broad Gram-negative coverage including E. coli, Klebsiella, H. influenzae, N. gonorrhoeae
4. Suitable for outpatient parenteral antibiotic therapy (OPAT)

How To Use:

1. For IV: Reconstitute and administer as slow IV push over 2–4 minutes or as infusion over 30 minutes.
2. For IM: Inject deeply into a large muscle (e.g., gluteus); may mix with 1% lidocaine to reduce pain.
3. Typical adult dosage:
4. Moderate infections: 500mg–1g once daily
5. Severe infections/meningitis: 2g once daily
6. Gonorrhea: Single 500mg IM dose (per WHO/Pakistan STI guidelines)
7. Duration: 5–14 days, based on infection severity.

When Not to Use:

Do not use if the patient has:

1. Hypersensitivity to cephalosporins or severe penicillin allergy
2. History of anaphylaxis to beta-lactam antibiotics
3. Neonatal hyperbilirubinemia (if ceftriaxone-based—displaces bilirubin from albumin)
4. Concomitant calcium-containing IV solutions (risk of precipitation in neonates)

Side Effects:

Common:

1. Local pain at IM injection site
2. Diarrhea, nausea
3. Rash, transient liver enzyme elevation

Less common:

1. Eosinophilia, leukopenia
2. Vaginal candidiasis

Serious (rare):

1. Clostridioides difficile-associated diarrhea (CDAD)
2. Anaphylaxis or Stevens-Johnson syndrome
3. Biliary pseudolithiasis (reversible gallbladder sludge with ceftriaxone)
4. Hemolytic anemia (immune-mediated)
5. Seek emergency care for breathing difficulty, severe rash, or persistent watery diarrhea.

Dosage Adjustments:

1. Renal impairment: No adjustment needed for ceftriaxone (excreted via bile)
2. Hepatic impairment: Reduce dose if both liver and kidney dysfunction present
3. Children: Dosed by weight (50–100 mg/kg/day; max 4g/day)

Who It’s For:

Adults and children with moderate to severe bacterial infections requiring hospitalization or parenteral therapy when oral options are unsuitable.

Warnings & Precautions:

1. Confirm bacterial etiology before initiating therapy
2. Avoid calcium-containing IV lines within 48 hours in neonates (if ceftriaxone)
3. Monitor for CDAD during and after treatment
4. Cross-reactivity with penicillins: ~5–10% in allergic patients

Drug Interactions:

1. Probenecid: May increase levels of some cephalosporins (not ceftriaxone)
2. Aminoglycosides: Additive nephrotoxicity (monitor renal function)
3. Oral anticoagulants: Ceftriaxone may enhance effects—monitor INR
4. Always inform your doctor about all medications.

Additional Information:

Store unreconstituted vials below 25°C. Reconstituted solution is stable for 24 hours at room temperature or up to 3 days refrigerated. Keep out of reach of children. Available by prescription only in Pakistan.